Merrimack Pharmaceuticals, Inc(MACK)
$15.000%
Market is closed - opens 7 PM, 07 May 2024
Insights
- Merrimack Pharmaceuticals, Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Merrimack Pharmaceuticals, Inc stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Merrimack Pharmaceuticals, Inc stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Merrimack Pharmaceuticals, Inc stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 76.46 | Sell |
Stochastic | 91.89, 96.29 | Sell |
Ultimate Oscillator | 63.48 | Neutral |
Stochastic Relative Strength Index | 94.32, 98.11 | Sell |
Moving Average Convergence Divergence | 0.07, 0.05 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.81 | Buy |
20 | 14.76 | Buy |
50 | 14.73 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.85 | Buy |
20 | 14.79 | Buy |
50 | 14.6 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.87 | Neutral |
20 | 14.8 | Neutral |
50 | 14.76 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.94 | Buy |
20 | 14.88 | Sell |
50 | 14.99 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.99 | Buy |
20 | 14.88 | Sell |
50 | 14.93 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 15.12 |
Resistance L2 | 15.08 |
Resistance L1 | 15.05 |
Pivot Point | 15.01 |
Support L1 | 14.98 |
Support L2 | 14.94 |
Support L3 | 14.91 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.